Product Name |
Paricalcitol D6 |
Alternate Names |
Paricalcitol Stable Isotopes, Stable Isotopes of Paricalcitol |
CAT No. |
CS-O-06853
|
CAS No. |
2070009-67-3 |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
422.67 g/mol |
Mol. For. |
C₂₇H₃₈D₆O₃
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Paricalcitol |
Purity |
98.53 |
Smileys |
C[C@]([C@@]1([H])[C@H](C)/C=C/[C@H](C)C(C([2H])([2H])[2H])(O)C([2H])([2H])[2H])(CCC/2)[C@](CC1)([H])C2=C\C=C(C[C@@H](O)C3)/C[C@H]3O |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Paricalcitol D6 is a deuterated form of Paricalcitol, which is a synthetic Vitamin D analog. It is primarily used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. The drug works by regulating the levels of parathyroid hormone (PTH) in the body, which is responsible for the maintenance of calcium and phosphate homeostasis. Patients with chronic kidney disease have impaired kidney function, which leads to an increase in PTH levels, resulting in mineral and bone disorders. Paricalcitol D6 helps reduce PTH levels, thereby improving bone health and reducing the risk of fractures.
The chemical formula of Paricalcitol D6 is C27H33D6NO3, and its molecular weight is 427.6 g/mol. The drug is administered orally, either as a capsule or as a liquid solution. It is metabolized in the liver and excreted through the feces. Paricalcitol D6 is a lipophilic compound, and its absorption is enhanced by the presence of food.
Paricalcitol D6 is a safe and effective drug for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. However, like all drugs, it may have some side effects, including nausea, vomiting, headache, and dizziness. It is important to consult a healthcare provider before taking Paricalcitol D6 to ensure that it is safe and appropriate for individual use.